WGRX
Company Description
Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 23.34M | 18.13M | 0 | 32.78M |
| Net Income | (101.27M) | (6.86M) | (2.90M) | (2.74M) |
| EPS | -1.43 | -0.13 | -0.06 | -0.06 |
| Free Cash Flow | (10.86M) | (1.60M) | (349,136) | 0 |
| FCF / Share | -0.15 | -0.03 | -0.01 | N/A |
| Operating CF | (10.86M) | (1.22M) | (349,136) | 0 |
| Total Assets | 30.46M | 57.33M | 338,364 | N/A |
| Total Debt | 24.58M | 25.11M | 700,000 | N/A |
| Cash & Equiv | 42,571 | 1.03M | 1,364 | N/A |
| Book Value | (12.45M) | 6.73M | (2.90M) | N/A |
| Return on Equity | N/A | -1.02 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.56M | 1.67M | 3.01M | 7.79M | 10.86M | (16.05M) | 15.80M | 10.44M | 7.94M | 34.37M | 0 | 0 |
| Net Income | (7.74M) | (27.85M) | (34.32M) | (6.67M) | (32.43M) | 355,285 | (3.05M) | (2.38M) | (1.77M) | (11.80M) | (903,312) | (428,764) |
| EPS | -0.07 | -0.27 | -0.46 | -0.11 | -0.62 | -0.08 | -0.04 | -0.01 | -0.04 | -0.25 | -0.02 | -0.01 |
| Free Cash Flow | (3.41M) | (6.55M) | (730,270) | (2.21M) | (1.62M) | (2.77M) | 1.11M | 77,770 | 31,240 | (462,056) | 112,940 | N/A |
| FCF / Share | -0.03 | -0.09 | -0.01 | -0.04 | -0.03 | -0.05 | 0.02 | 0.00 | 0.00 | -0.01 | 0.00 | N/A |
| Operating CF | (3.41M) | (6.29M) | (1.14M) | (2.08M) | (1.35M) | (2.66M) | 1.33M | 77,774 | 31,237 | (462,056) | 112,940 | N/A |
| Total Assets | 30.13M | 30.46M | 52.78M | 54.23M | 58.06M | 57.33M | 55.57M | 44.66M | 34.68M | 338,364 | N/A | N/A |
| Total Debt | 28.73M | 24.58M | 26.20M | 24.87M | 25.74M | 25.11M | 22.08M | 23.24M | 18.45M | 700,000 | N/A | N/A |
| Cash & Equiv | 51,730 | 42,571 | 4.23M | 419,942 | 2.52M | 1.03M | 793,148 | 2.07M | 917,140 | 1,364 | N/A | N/A |
| Book Value | (15.06M) | (12.45M) | 6.78M | 905,255 | 4.48M | 6.73M | 9.99M | (967,126) | (93) | (2.90M) | N/A | N/A |
| Return on Equity | N/A | N/A | -5.06 | -7.37 | -7.24 | 0.05 | -0.31 | N/A | N/A | N/A | N/A | N/A |